Cargando…

Improving phase ii oncology trial using best observed RECIST response as an endpoint by modelling continuous tumour measurements

Detalles Bibliográficos
Autores principales:	Lin, Chien-Ju, Wason, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660152/ http://dx.doi.org/10.1186/1745-6215-16-S2-P63

Ejemplares similares

Improving phase II oncology trials using best observed RECIST response as an endpoint by modelling continuous tumour measurements
por: Lin, Chien‐Ju, et al.
Publicado: (2017)

Using continuous data on tumour measurements to improve inference in phase II cancer studies
por: Wason, James, et al.
Publicado: (2013)

Imaging tumour response: beyond RECIST
por: Koh, Dow-Mu
Publicado: (2014)

RECIST criteria: our experience in daily practice
por: De Luca, S, et al.
Publicado: (2015)

Analysis of composite endpoints in gene expression studies in oncology
por: Marhoon, ZA, et al.
Publicado: (2015)

The use of historical priors to improve the efficiency of phase II clinical trials with time-to-event endpoints
por: Jackson, Richard, et al.
Publicado: (2013)

Imaging endpoints for clinical trial use: a RECIST perspective
por: Litière, Saskia, et al.
Publicado: (2022)

Using continuous data on tumour measurements to improve inference in phase II cancer studies
por: Wason, James MS, et al.
Publicado: (2013)

Efficient analysis of time-to-event endpoints when the event involves a continuous variable crossing a threshold
por: Lin, Chien-Ju, et al.
Publicado: (2020)

An adaptive trial design for updating the threshold of a continuous biomarker
por: Spencer, Amy, et al.
Publicado: (2015)

Independent endpoint event review for the elimination of reporting bias in an open label phase III pharmaceutical trial
por: Hall, Peter, et al.
Publicado: (2015)

Response assessment in daily practice: RECIST and its modifications
por: Sohaib, Aslam
Publicado: (2014)

Identification of continued challenges and opportunities in oncologists' comprehension of immuno-oncology
por: Herrmann, Tara, et al.
Publicado: (2015)

The choice of test in phase II cancer trials assessing continuous tumour shrinkage when complete responses are expected
por: Wason, James MS, et al.
Publicado: (2015)

Statistical evaluation of surrogate endpoints: a systematic review
por: Ensor, Hannah, et al.
Publicado: (2013)

Optimized scaling of translational factors in oncology: from xenografts to RECIST
por: Baaz, Marcus, et al.
Publicado: (2022)

iRECIST and atypical patterns of response to immuno-oncology drugs
por: Ramon-Patino, Jorge Luis, et al.
Publicado: (2022)

Analysis of responder-based endpoints: improving power through utilising continuous components
por: Wason, James, et al.
Publicado: (2020)

RECIST rules
por: Sohaib, Aslam
Publicado: (2012)

Best precision in measuring Qp/Qs is achieved with quadratic, not linear, stationary tissue background correction in phase contrast velocity encoded CMR
por: Nickander, Jannike, et al.
Publicado: (2016)

Phase II trial designs for complex interventions: a single-arm single-stage design for clustered continuous outcomes
por: Wilson, Duncan T, et al.
Publicado: (2015)

CMR endpoints for clinical trials: impact of operator experience on the accuracy of image analysis
por: McAlindon, Elisa, et al.
Publicado: (2012)

An adaptive seamless phase II/III clinical trial design incorporating short-term endpoint information
por: Stallard, Nigel
Publicado: (2011)

The feasibility and validity of a preference-weighted composite endpoint to establish value in geriatric care
por: Hofman, Cynthia, et al.
Publicado: (2014)

Endpoint resuscitation-based prediction model for early mortality of severe sepsis and septic shock
por: Sinto, R, et al.
Publicado: (2014)

RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline
por: van Persijn van Meerten, Els L., et al.
Publicado: (2009)

The win ratio method: a novel hierarchical endpoint for pneumonia trials in patients on mechanical ventilation
por: Montgomery, A, et al.
Publicado: (2014)

Continuous cardiac output measurement: effect of time
por: De Wilde, R, et al.
Publicado: (2010)

Endpoint surrogacy in oncology Phase 3 randomised controlled trials
por: Zhang, Jianrong, et al.
Publicado: (2020)

APACHE II and SOFA scores for intensive care and hospital outcome prediction in oncologic patients
por: Forte, DN, et al.
Publicado: (2007)

Simulation work in adaptive dose-finding designs to identify dose-intervals that achieve targets in multiple endpoints
por: Howlett, James, et al.
Publicado: (2015)

Phosphocreatine recovery time constant (PCr) at peak exercise as a potential endpoint for clinical trials in PAD
por: Gonzalez, Jorge A, et al.
Publicado: (2016)

Information-theoretic model averaging: a useful method for modelling exploratory secondary endpoints in clinical trials
por: Lythgoe, Daniel
Publicado: (2013)

RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the GERCOR NIPICOL phase II study
por: Cohen, Romain, et al.
Publicado: (2020)

The best way to skin a cat: product consumption versus direct observation for monitoring hand hygiene performance
por: Stewardson, AJ, et al.
Publicado: (2011)

A flexible design for advanced Phase I/II clinical trials with continuous efficacy endpoints
por: Mozgunov, Pavel, et al.
Publicado: (2019)

Reliability of continuous pulse contour cardiac output measurement
por: Weng, L, et al.
Publicado: (2008)

Use of an online e-learning module to standardise the assessment and reporting of a subjective endpoint in a multicentre rct
por: Pinkney, Thomas, et al.
Publicado: (2013)

A comparison of bayesian adaptive randomization and multi-stage designs for multi-arm clinical trials
por: Wason, James, et al.
Publicado: (2013)

Use of an embedded, micro-randomised trial to investigate non-compliance in telehealth trials
por: Law, Lisa, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8g5i1g1de54qhppi63j84p29s2